ARCHIVES

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Komen Foundation Breast Cancer Awards

April 15, 1994

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014